A simplified new method for HLA-DR typing using the TM1 monoclonal antibody

Area of Science:

• Immunogenetics
• Cellular Immunology
• Histocompatibility

Background:

• Human Leukocyte Antigen (HLA) typing is crucial for transplantation and autoimmune disease research.
• Current HLA-DR typing methods can be time-consuming and complex compared to HLA-A,B,C typing.
• Efficient and rapid HLA-DR typing techniques are needed to streamline clinical and research workflows.

Purpose of the Study:

• To introduce and validate a new, simplified method for HLA-DR typing, termed the TM1 technique.
• To compare the efficacy of the TM1 technique with existing HLA-DR typing methodologies.
• To assess the applicability of the TM1 technique across various sample conditions, including cryopreserved and aged blood samples.

Main Methods:

• The TM1 technique involves labeling peripheral blood lymphocytes with carboxyfluoresceindiacetate.
• T cells are selectively lysed using TM1, a pan-T cytotoxic IgM monoclonal antibody.
• Residual B-cell reactivity against cytotoxic DR alloantibodies is measured using fluorochromasia microlymphocytotoxicity.

Main Results:

• The TM1 technique demonstrated comparable or superior performance to methods using enriched B cells (e.g., sheep red blood cell rosetting, Degalan beads).
• The technique proved effective with cryopreserved cells and whole blood samples up to three days post-collection.
• The method significantly simplifies HLA-DR typing, achieving speeds similar to routine HLA-A,B,C typing.

Conclusions:

• The TM1 technique offers a rapid, simple, and effective approach to HLA-DR typing.
• This method is robust and versatile, accommodating various sample types and storage conditions.
• The TM1 antibody's T-cell depleting capacity may also be valuable for functional immunological studies.